Brief: Inception and Celgene enter strategic collaboration to advance novel therapeutics for inflammatory bowel disease
Dec 10 (Reuters) - Inception IBD Inc: * Co and Celgene enter strategic collaboration to advance novel therapeutics for inflammatory bowel disease * Ibd inc - under terms, Inception ibd is eligible to receive up to US$40 million in cash payments during the course of the collaboration * Source text for Eikon ID:nBw3bNKhpa * Further company coverage ((Bengaluru Newsroom; +1 646 223 8780))